Analysts expect Abbott Laboratories to report revenue of 12.39 B for Q4 26, against a range of 11.51 B to 13.27 B. The most recent reported quarter, Q3 26, came in at 13.01 B, a 2.5% beat against the 12.70 B consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 10.97 B | 10.36 B | 11.14 B | 11.37 B | 11.46 B | 11.16 B | 12.59 B | 13.01 B | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 12.07 B | 10.74 B | 12.06 B | 11.42 B | 11.39 B | 12.26 B | 12.63 B | 13.49 B | 13.27 B | 12.90 B | 13.28 B | 13.37 B | 14.12 B | 13.52 B | 15.55 B | 14.88 B | |||||||||
| Low Estimate | 10.82 B | 9.43 B | 10.91 B | 10.28 B | 10.62 B | 10.23 B | 11.67 B | 11.91 B | 11.51 B | 11.13 B | 12.34 B | 12.43 B | 12.25 B | 11.99 B | 14.63 B | 13.19 B | |||||||||
| Consensus Estimate | 11.45 B | 10.08 B | 11.48 B | 10.85 B | 11.01 B | 11.25 B | 12.15 B | 12.70 B | 12.39 B | 12.01 B | 12.81 B | 12.90 B | 13.19 B | 12.76 B | 15.09 B | 14.03 B |
Analysts expect Abbott Laboratories to report earnings per share of 1.58 for Q4 26, against a range of 1.48 to 1.68. The most recent reported quarter, Q3 26, came in at 1.42, a 4.7% miss against the 1.49 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.34 | 1.09 | 1.26 | 1.30 | 1.50 | 1.15 | 1.31 | 1.42 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 1.30 | 1.22 | 1.43 | 1.34 | 1.64 | 1.17 | 1.40 | 1.57 | 1.68 | 1.35 | 1.48 | 1.79 | 1.83 | 1.36 | 1.76 | 1.65 | |||||||||
| Low Estimate | 1.22 | 1.04 | 1.19 | 1.16 | 1.50 | 0.97 | 1.32 | 1.41 | 1.48 | 1.17 | 1.30 | 1.49 | 1.53 | 1.18 | 1.50 | 1.49 | |||||||||
| Consensus Estimate | 1.26 | 1.13 | 1.31 | 1.25 | 1.57 | 1.07 | 1.36 | 1.49 | 1.58 | 1.26 | 1.39 | 1.64 | 1.68 | 1.27 | 1.63 | 1.57 |
Pull Wall Street consensus for Abbott Laboratories (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ABT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ABT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ABT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();